LivaNova Plc

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00BYMT0J19
USD
63.90
0.22 (0.35%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About LivaNova Plc stock-summary
stock-summary
LivaNova Plc
Pharmaceuticals & Biotechnology
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company's segments include Cardiac Surgery and Neuromodulation. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products. Cardiac Surgery products include oxygenators, heart-lung machines, autotransfusion, mechanical heart valves and tissue heart valves. The Neuromodulation segment is engaged in the design, development and marketing of neuromodulation therapy for the treatment of drug-resistant epilepsy and treatment resistant depression.
Company Coordinates stock-summary
Company Details
20 Eastbourne Terrace , LONDON None : W2 6LG
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 74 Schemes (45.8%)

Foreign Institutions

Held by 125 Foreign Institutions (15.31%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Daniel Moore
Independent Chairman of the Board
Mr. Damien McDonald
Chief Executive Officer, Director
Mr. Todd Schermerhorn
Director
Mr. Francesco Bianchi
Independent Director
Mr. William Kozy
Independent Director
Mr. Alfred Novak
Independent Director
Dr. Sharon O'Kane
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
353 Million
(Quarterly Results - Jun 2025)
Net Profit:
27 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 3,214 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.14

stock-summary
Return on Equity

-23.82%

stock-summary
Price to Book

2.86